$Pfizer (PFE.US)$ This is originally a defensive stock, and it will likely remain in the range of 25-30 dollars for a long time over the past year, unless they develop a pioneering product in their cancer Pharmaceuticals. Other than that, don't expect too much from this stock. Hold on to it well, increase holdings when it is below 26, and use the dividends to invest in other company stocks for profit. No need to complain too much, nor should there be much expectation that ordinary news will significantly affect its stock price. Furthermore, selling for profit after the stock price exceeds 35 dollars is the end of it, and the probability of it going over 50 dollars is comparable to the probability of a woman over 50 naturally conceiving. Everyone, relax and don't get too tangled up.

$Pfizer (PFE.US)$
Tomorrow is the earnings release. Hope for the best results

$Pfizer (PFE.US)$ Prepare for a decline

$Pfizer (PFE.US)$ This ticket is completely fine. It has been making money all along. Buy in batches, sell cc, enjoy dividends. Support moves a bit. It's a cycle. Always keep some in hand waiting for a big rise and to enjoy dividends.

$Pfizer (PFE.US)$Currently, there is no support at the small level, and there is no sign of stopping the decline on the daily and weekly charts. Only two days left this week.

Hello mooers,
What an incredible journey it has been! Our Global Paper Trading Challenge has officially concluded, and the results are nothing short of spectacular. With participants from across seven markets, let's celebrate the achievements and strides made in these past five weeks.
Challenge Highlights:
The sheer scale of this challenge was monumental, with registrations breaking past 150,000! This milestone is a test...

$Spirit Airlines (SAVE.US)$ Will this court ruling bankrupt the company? Is it not more disadvantageous for consumers if it goes out of business? We also need to consider the situation of anti-trust.